Edition:
United Kingdom

Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

61.95USD
18 Jul 2019
Change (% chg)

$0.63 (+1.03%)
Prev Close
$61.32
Open
$61.24
Day's High
$62.00
Day's Low
$60.80
Volume
82,871
Avg. Vol
181,158
52-wk High
$62.63
52-wk Low
$31.98

About

Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the... (more)

Overall

Beta: 1.42
Market Cap(Mil.): $3,039.64
Shares Outstanding(Mil.): 49.57
Dividend: --
Yield (%): --

Financials

  ARNA.OQ Industry Sector
P/E (TTM): 5.05 96.93 34.10
EPS (TTM): 12.15 -- --
ROI: 64.15 7.71 12.64
ROE: 68.14 8.16 17.18

Earnings vs. Estimates